Noninvasive Markers of Portal Hypertension Detect Decompensation in Overweight or Obese Patients With Compensated Advanced Chronic Liver Disease

被引:18
|
作者
Mendoza, Yuly [1 ]
Cocciolillo, Sila [2 ]
Chen, Tianyan [1 ]
Margini, Cristina [2 ]
Sebastiani, Giada [1 ]
Berzigotti, Annalisa [2 ]
Murgia, Giuseppe [1 ]
机构
[1] Univ Bern, Bern Univ Hosp, Inselspital, Univ Clin Visceral Surg & Med,Dept Biomed Res, Bern, Switzerland
[2] McGill Univ, Royal Victoria Hosp, Div Gastroenterol & Hepatol, Hlth Ctr, Montreal, PQ, Canada
关键词
Cirrhosis; Ultrasound; NASH; Fibrosis; CONTROLLED ATTENUATION PARAMETER; STIFFNESS MEASUREMENT; RISK; COMPLICATIONS; PREDICTION; FIBROSIS;
D O I
10.1016/j.cgh.2020.04.018
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BACKGROUND & AIMS: Some patients with compensated advanced chronic liver disease (cACLD) require use of an extralarge probe for liver stiffness measurement (LSM), owing to overweight or obesity. However, the ability of noninvasive markers of portal hypertension and the controlled attenuation parameter (CAP) to determine which of these patients are at risk for decompensation has not been fully assessed. METHODS: We collected data from 272 patients with cACLD (LSM double dagger 10 kPa by XL probe; 57% with nonalcoholic steatohepatitis; mean body mass index, 33.8 6.5 kg/m2; median Child-Pugh score, 5; median LSM, 16.8 kPa; mean CAP, 318 66 dB/m) evaluated at 2 academic centers from 2015 through 2018. We collected clinical data on decompensation (ascites, portal hypertension bleeding, jaundice, hepatic encephalopathy) and severe bacterial infections; patients were followed up for a median of 17 months (interquartile range, 11-24 mo). We evaluated associations between these events and LSM, CAP, LSM*spleen size/platelet count (LSPS), and portal hypertension risk scores. RESULTS: Decompensation occurred in 12 patients and severe bacterial infections developed in 5 patients. LSM, LSPS, and the portal hypertension risk score identified patients with decompensation with area under the receiver operating characteristic curve values of 0.848 (95% CI, 0.720-0.976; P < .0001), 0.881 (95% CI, 0.798-0.954; P < .0001), and 0.890 (95% CI, 0.814-0.966; P < .0001), respectively. In multivariate Cox regression analysis, in patients with nonalcoholic steatohepatitis, LSM and CAP were associated independently with decompensation and severe bacterial infection; CAP >= 220 dB/m was associated with a reduced risk of decompensation (hazard ratio, 0.043, 95% CI, 0.004-0.476; P =.01). CONCLUSIONS: LSM, LSPS, and the portal hypertension risk score identify obese or overweight patients with cACLD who are at increased risk of decompensation and severe bacterial infection.
引用
收藏
页码:3017 / +
页数:15
相关论文
共 50 条
  • [21] Splenomegaly is a marker of advanced chronic liver disease and portal hypertension in HIV infection
    Kablawi, Dana
    Alhinai, Alshaima
    Wong, Philip
    Deschenes, Marc
    Sebastiani, Giada
    Benmassaoud, Amine
    HIV MEDICINE, 2023, 24 (03) : 366 - 371
  • [22] Liver stiffness measurement trajectory analysis for prognosis in patients with chronic hepatitis B and compensated advanced chronic liver disease
    Jiang, Hao
    Yu, Hongsheng
    Hu, Can
    Huang, Yinan
    Yang, Bilan
    Xi, Xiaoli
    Lei, Yiming
    Wu, Bin
    Yang, Yidong
    ANNALS OF HEPATOLOGY, 2025, 30 (01)
  • [23] Performance of Controlled Attenuation Parameter in Patients with Advanced Chronic Liver Disease and Portal Hypertension
    Georg Semmler
    Judith Stift
    Bernhard Scheiner
    Katharina Wöran
    Philipp Schwabl
    Rafael Paternostro
    Theresa Bucsics
    Albert Friedrich Stättermayer
    Matthias Pinter
    Arnulf Ferlitsch
    Michael Trauner
    Thomas Reiberger
    Mattias Mandorfer
    Digestive Diseases and Sciences, 2019, 64 : 3642 - 3651
  • [24] Assessment of the Performance of Non-invasive Criteria for the Evaluation of Clinically Significant Portal Hypertension in Patients with Compensated Advanced Chronic Liver Disease
    Ankur Jindal
    Samagra Agarwal
    Sanchit Sharma
    Manoj Kumar
    Anoop Saraya
    Shiv Kumar Sarin
    Digestive Diseases and Sciences, 2023, 68 : 2149 - 2157
  • [25] Baveno VII criteria to predict decompensation in compensated advanced chronic liver disease: Still some shades of grey
    Rodrigues, Susana G.
    CLINICAL AND MOLECULAR HEPATOLOGY, 2023, 29 (01) : 110 - 112
  • [26] The role of microRNAs on the pathogenesis, diagnosis and management of portal hypertension in patients with chronic liver disease
    Selvakumar, Sushmaa Chandralekha
    Preethi, K. Auxzilia
    Veeraiyan, Deepak Nallaswamy
    Sekar, Durairaj
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2022, 16 (10) : 941 - 951
  • [27] Von Willebrand factor as new noninvasive predictor of portal hypertension, decompensation and mortality in patients with liver cirrhosis
    Ferlitsch, Monika
    Reiberger, Thomas
    Hoke, Matthias
    Salzl, Petra
    Schwengerer, Bernadette
    Ulbrich, Gregor
    Payer, Berit Anna
    Trauner, Michael
    Peck-Radosavljevic, Markus
    Ferlitsch, Arnulf
    HEPATOLOGY, 2012, 56 (04) : 1439 - 1447
  • [28] Relationship between Tetrahydrobiopterin and Portal Hypertension in Patients with Chronic Liver Disease
    Hong, Won Ki
    Shim, Kwang Yong
    Baik, Soon Koo
    Kim, Moon Young
    Cho, Mee Yon
    Jang, Yoon Ok
    Park, Young Shik
    Han, Jin
    Kim, Gaeun
    Cho, Youn Zoo
    Hwang, Hye Won
    Lee, Jin Hyung
    Chae, Myeong Hun
    Kwon, Sang Ok
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2014, 29 (03) : 392 - 399
  • [29] Noninvasive Risk Stratification After HCV Eradication in Patients With Advanced Chronic Liver Disease
    Semmler, Georg
    Binter, Teresa
    Kozbial, Karin
    Schwabl, Philipp
    Hametner-Schreil, Stefanie
    Zanetto, Alberto
    Gavasso, Sabrina
    Chromy, David
    Bauer, David J. M.
    Simbrunner, Benedikt
    Scheiner, Bernhard
    Bucsics, Theresa
    Staettermayer, Albert F.
    Pinter, Matthias
    Steindl-Munda, Petra
    Schoefl, Rainer
    Russo, Francesco Paolo
    Simioni, Paolo
    Trauner, Michael
    Ferenci, Peter
    Reiberger, Thomas
    Mandorfer, Mattias
    HEPATOLOGY, 2021, 73 (04) : 1275 - 1289
  • [30] Supersonic Shear Imaging and Transient Elastography With the XL Probe Accurately Detect Fibrosis in Overweight or Obese Patients With Chronic Liver Disease
    Yoneda, Masato
    Thomas, Emmanuel
    Sclair, Seth N.
    Grant, Tiffannia T.
    Schiff, Eugene R.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2015, 13 (08) : 1502 - +